BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23824949)

  • 1. Cell death in the myocardium: my heart won't go on.
    Orogo AM; Gustafsson ÅB
    IUBMB Life; 2013 Aug; 65(8):651-6. PubMed ID: 23824949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.
    Del Re DP; Amgalan D; Linkermann A; Liu Q; Kitsis RN
    Physiol Rev; 2019 Oct; 99(4):1765-1817. PubMed ID: 31364924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cell death in the progression of heart failure.
    Moe GW; Marín-García J
    Heart Fail Rev; 2016 Mar; 21(2):157-67. PubMed ID: 26872675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell death in the pathogenesis of heart disease: mechanisms and significance.
    Whelan RS; Kaplinskiy V; Kitsis RN
    Annu Rev Physiol; 2010; 72():19-44. PubMed ID: 20148665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Death in the Cardiac Myocyte.
    Marunouchi T; Tanonaka K
    Biol Pharm Bull; 2015; 38(8):1094-7. PubMed ID: 26235571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria play a central role in nonischemic cardiomyocyte necrosis: common to acute and chronic stressor states.
    Khan MU; Cheema Y; Shahbaz AU; Ahokas RA; Sun Y; Gerling IC; Bhattacharya SK; Weber KT
    Pflugers Arch; 2012 Jul; 464(1):123-31. PubMed ID: 22328074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria in Ischemic Heart Disease.
    Maximilian Buja L
    Adv Exp Med Biol; 2017; 982():127-140. PubMed ID: 28551785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New roles for mitochondria in cell death in the reperfused myocardium.
    Ong SB; Gustafsson AB
    Cardiovasc Res; 2012 May; 94(2):190-6. PubMed ID: 22108916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
    Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
    Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mitochondrial permeability transition pore as a target of cardioprotective signaling.
    Baines CP
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H903-4. PubMed ID: 17513492
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardioprotective Role of Tumor Necrosis Factor Receptor-Associated Factor 2 by Suppressing Apoptosis and Necroptosis.
    Guo X; Yin H; Li L; Chen Y; Li J; Doan J; Steinmetz R; Liu Q
    Circulation; 2017 Aug; 136(8):729-742. PubMed ID: 28572508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure-induced activation of phospholipase iPLA
    Moon SH; Liu X; Cedars AM; Yang K; Kiebish MA; Joseph SM; Kelley J; Jenkins CM; Gross RW
    J Biol Chem; 2018 Jan; 293(1):115-129. PubMed ID: 29158256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.
    Zhang T; Zhang Y; Cui M; Jin L; Wang Y; Lv F; Liu Y; Zheng W; Shang H; Zhang J; Zhang M; Wu H; Guo J; Zhang X; Hu X; Cao CM; Xiao RP
    Nat Med; 2016 Feb; 22(2):175-82. PubMed ID: 26726877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ellagic acid antagonizes Bnip3-mediated mitochondrial injury and necrotic cell death of cardiac myocytes.
    Dhingra A; Jayas R; Afshar P; Guberman M; Maddaford G; Gerstein J; Lieberman B; Nepon H; Margulets V; Dhingra R; Kirshenbaum LA
    Free Radic Biol Med; 2017 Nov; 112():411-422. PubMed ID: 28838842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury.
    Davidson SM; Adameová A; Barile L; Cabrera-Fuentes HA; Lazou A; Pagliaro P; Stensløkken KO; Garcia-Dorado D;
    J Cell Mol Med; 2020 Apr; 24(7):3795-3806. PubMed ID: 32155321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria as a therapeutic target for cardiac ischemia‑reperfusion injury (Review).
    Marin W; Marin D; Ao X; Liu Y
    Int J Mol Med; 2021 Feb; 47(2):485-499. PubMed ID: 33416090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting mitochondria for cardioprotection: examining the benefit for patients.
    Dongworth RK; Hall AR; Burke N; Hausenloy DJ
    Future Cardiol; 2014 Mar; 10(2):255-72. PubMed ID: 24762253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial involvement in myocyte death and heart failure.
    Goldenthal MJ
    Heart Fail Rev; 2016 Mar; 21(2):137-55. PubMed ID: 26886225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of apoptosis in cardiovascular disease.
    Lee Y; Gustafsson AB
    Apoptosis; 2009 Apr; 14(4):536-48. PubMed ID: 19142731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow calcium waves and redox changes precede mitochondrial permeability transition pore opening in the intact heart during hypoxia and reoxygenation.
    Davidson SM; Yellon DM; Murphy MP; Duchen MR
    Cardiovasc Res; 2012 Mar; 93(3):445-53. PubMed ID: 22198507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.